Eye imaging study for central serous chorioretinopathy

This trial tests whether faricimab (a medicine injected into the eye) can help reduce fluid buildup in patients with chronic central serous chorioretinopathy (CSCR). It compares the drug to a sham injection to see if it improves vision and reduces fluid.

This study uses advanced eye imaging (OCT and OCTA) to understand how the blood vessels and tissue layers in the back of the eye differ between people with glaucoma, people at risk for angle-closure glaucoma, and people with healthy eyes. The findings may help doctors better diagnose and understand these eye conditions.

This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.

This trial studies rare diseases affecting the retina or choroid using detailed eye scans (OCT). It may help doctors better understand how these conditions look in the eye and how imaging findings relate to vision.

This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.

This study uses a special eye scan (OCTA) to check the health of tiny blood vessels in the back of the eye. It may help doctors understand small vessel disease in the brain and find easier ways to monitor it.